Recent reorganizations and "reductions in force" at the FDA have damaged the very backbone of our public health system.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with Trump order on gender.

Rarely considered a priority region for U.S. foreign policy, Latin America has come to the forefront during the first few ...

Helping Walt Geister fulfill his final wish I’m reaching out on behalf of a beloved longtime local going through an extremely hard time. Walt Geister moved to Aspen in 1970 and worked at the ...

Top officials at the National Institutes of Health, the Centers for Disease Control and Prevention, and the Food and Drug Administration were put on ... (Weber, 4/1) MedPage Today: Musk, DOGE Created ...

As Donald Trump completes the first 100 days of his second term, the consequences of his early health care decisions are ...

President Donald Trump and his administration have gutted science agencies, terminated research programmes and cancelled ...

Defense Department data shows the uptick began well before Trump's reelection and experts point to actions by the Biden ...

Alexandra Sifferlin, a health and science editor for Times Opinion, hosted a written conversation with the Opinion columnist ...

Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why ...